OWEN O OSAGIE
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- ROSENBERG, TX
- NPI
- 1164534426
- Received
- $9,546 in 462 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 98 | $2,280 |
| 2024 | General payment | 48 | $1,241 |
| 2023 | General payment | 63 | $1,206 |
| 2022 | General payment | 53 | $1,133 |
| 2021 | General payment | 85 | $1,660 |
| 2020 | General payment | 43 | $826 |
| 2019 | General payment | 72 | $1,196 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 72 | $2,054 | 2020–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 57 | $1,172 | 2020–2025 |
| Otsuka America Pharmaceutical, Inc. | 55 | $1,042 | 2019–2025 |
| Neurocrine BioSciences, Inc. | 51 | $995 | 2019–2025 |
| Alkermes, Inc. | 31 | $919 | 2019–2023 |
| Janssen Pharmaceuticals, Inc | 47 | $699 | 2019–2025 |
| Sunovion Pharmaceuticals Inc. | 22 | $406 | 2019–2022 |
| ABBVIE INC. | 19 | $345 | 2021–2023 |
| IRONSHORE PHARMACEUTICALS INC. | 16 | $327 | 2019–2024 |
| Indivior Inc. | 19 | $308 | 2019–2024 |
| E.R. Squibb & Sons, L.L.C. | 17 | $268 | 2024–2025 |
| Allergan, Inc. | 17 | $261 | 2019–2020 |
| Supernus Pharmaceuticals, Inc. | 14 | $213 | 2021–2025 |
| Corium, LLC | 8 | $193 | 2021–2022 |
| Vanda Pharmaceuticals Inc. | 8 | $185 | 2019–2025 |
| Noven Therapeutics, LLC | 2 | $33 | 2020 |
| Almatica Pharma LLC | 1 | $27 | 2021 |
| LivaNova USA, Inc. | 1 | $19 | 2021 |
| Axsome Therapeutics, Inc. | 1 | $17 | 2025 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 | 2022 |
| Neuronetics, Inc. | 1 | $14 | 2019 |
| Eisai Inc. | 1 | $13 | 2020 |
| Adlon Therapeutics L.P. | 1 | $11 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 455 | $9,036 |
| Education | 7 | $509 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-01 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-11-25 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-18 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-11-12 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-11-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $9 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-10 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-06 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-11-05 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-30 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-28 | Teva Pharmaceuticals USA, Inc. | $29 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-23 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-21 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-10-20 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-17 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-16 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-15 | E.R. Squibb & Sons, L.L.C. | $8 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-15 | E.R. Squibb & Sons, L.L.C. | $3 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | Vanda Pharmaceuticals Inc. | $14 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-08 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-07 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-09-24 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-09-23 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-23 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-09-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-11 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-10 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-09 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-19 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-08-18 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-14 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-12 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-08-07 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-30 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-07-28 | E.R. Squibb & Sons, L.L.C. | $5 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-28 | E.R. Squibb & Sons, L.L.C. | $2 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-18 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-17 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-15 | Teva Pharmaceuticals USA, Inc. | $109 | Education | In-kind items and services | 2025 | ||
| 2025-07-15 | Teva Pharmaceuticals USA, Inc. | $10 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-09 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-07-09 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-01 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-24 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-06-18 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-06-17 | Teva Pharmaceuticals USA, Inc. | $104 | Education | In-kind items and services | 2025 | ||
| 2025-06-10 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-06-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-05 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-30 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-29 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-05-21 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-14 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-13 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-13 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-05-08 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-06 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-05-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-30 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-04-29 | Teva Pharmaceuticals USA, Inc. | $102 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-04-22 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-04-22 | Otsuka America Pharmaceutical, Inc. | $8 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-21 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-04-15 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-04-10 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-04-09 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-08 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-04-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-01 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-03-27 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-03-26 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-19 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-03-13 | Supernus Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-03-11 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-03-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-04 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-02-20 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-19 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-14 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-13 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-02-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-02-11 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-04 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-01-28 | Teva Pharmaceuticals USA, Inc. | $118 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-01-28 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-01-23 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-16 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-16 | Otsuka America Pharmaceutical, Inc. | $0 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-07 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2024-12-13 | Neurocrine BioSciences, Inc. | $29 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-12 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-11 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-12-03 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-11-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-31 | E.R. Squibb & Sons, L.L.C. | $28 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Psychiatry/Psychology | 2024 | |
| 2024-10-30 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-10-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-15 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-10 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-10-08 | Teva Pharmaceuticals USA, Inc. | $106 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-09-26 | Teva Pharmaceuticals USA, Inc. | $113 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-09-20 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-09-18 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-09-12 | E.R. Squibb & Sons, L.L.C. | $22 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-09-11 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-09-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-20 | Janssen Pharmaceuticals, Inc | $127 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-13 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-08-12 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-07 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-07-31 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-07-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-01 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-06-25 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-06-14 | Indivior Inc. | $29 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2024 | |
| 2024-06-13 | IRONSHORE PHARMACEUTICALS INC. | $13 | Food and Beverage | Cash or cash equivalent | JORNAY PM Drug, CENTRAL NERVOUS SYSTEM STIMULANT | 2024 | |
| 2024-06-11 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-06-04 | Teva Pharmaceuticals USA, Inc. | $105 | Education | In-kind items and services | 2024 | ||
| 2024-06-04 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-13 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-03 | Indivior Inc. | $13 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2024 | |
| 2024-03-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-03-18 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-03-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-03-08 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-03-06 | Indivior Inc. | $20 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2024 | |
| 2024-02-22 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-02-08 | Teva Pharmaceuticals USA, Inc. | $10 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-02-08 | Teva Pharmaceuticals USA, Inc. | $1 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-02-07 | Janssen Pharmaceuticals, Inc | $8 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-01-31 | Indivior Inc. | $18 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2024 | |
| 2024-01-29 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-01-10 | Neurocrine BioSciences, Inc. | $22 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2023-12-14 | Indivior Inc. | $15 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-12-13 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-12-08 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-12-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-11-15 | Teva Pharmaceuticals USA, Inc. | $12 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-11-07 | Indivior Inc. | $14 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-10-30 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-10-25 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-10-24 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-10-20 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-10-19 | Supernus Pharmaceuticals, Inc. | $17 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-10-12 | Indivior Inc. | $14 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-10-05 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-21 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-09-15 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-09-14 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-09-05 | Indivior Inc. | $17 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-09-01 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-08-30 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-08-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-07-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $12 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-07-20 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-07-20 | Teva Pharmaceuticals USA, Inc. | $9 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-07-17 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-07-11 | Teva Pharmaceuticals USA, Inc. | $93 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2023 | |
| 2023-07-11 | Otsuka America Pharmaceutical, Inc. | $11 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-06-29 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-06-20 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-06-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-06-15 | Teva Pharmaceuticals USA, Inc. | $9 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-06-14 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-06-08 | Teva Pharmaceuticals USA, Inc. | $7 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-06-01 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-05-30 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-05-30 | Indivior Inc. | $14 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-05-25 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-05-24 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-05-02 | Teva Pharmaceuticals USA, Inc. | $7 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-04-28 | Alkermes, Inc. | $15 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-04-26 | Indivior Inc. | $17 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-04-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-04-17 | Teva Pharmaceuticals USA, Inc. | $15 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-04-13 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-04-05 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-04-05 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-03-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2023 | |
| 2023-03-09 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-03-02 | Supernus Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | QELBREE Drug, PSYCHOLOGY | 2023 | |
| 2023-03-01 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2023 | |
| 2023-02-28 | Otsuka America Pharmaceutical, Inc. | $124 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-02-21 | Indivior Inc. | $15 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-02-16 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 |
The latest 200 records of 462.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Rosenberg, TX, county Fort Bend County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Rosenberg, TX | County Fort Bend County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 40,646 | 893,767 | 30,188,424 |
| Population, 2020 census P1 | 38,282 | 822,779 | 29,145,505 |
| Median age B01002 | 32.8 | 37.3 | 35.6 |
| Under 18 B01001 | 24.4% | 26.6% | 25.0% |
| 65 and over B01001 | 12.7% | 12.6% | 13.4% |
| Households B11001 | 15,140 | 292,713 | 10,992,816 |
| Foreign born B05002 | 22.7% | 30.5% | 17.6% |
| Median household income B19013 | $65,668 | $114,041 | $78,476 |
| Median family income B19113 | $73,704 | $129,136 | $94,599 |
| Per capita income B19301 | $28,680 | $47,992 | $40,752 |
| Poverty rate B17001 | 20.2% | 7.6% | 13.8% |
| Unemployment rate B23025 | 5.9% | 5.1% | 5.3% |
| Civilian labor force B23025 | 20,391 | 455,656 | 15,233,563 |
| Mean commute (minutes) B08013 | 30.2 | 32.7 | 26.7 |
| Bachelor's degree or higher B15003 | 20.3% | 50.2% | 33.8% |
| Housing units B25001 | 16,070 | 305,633 | 12,128,515 |
| Owner-occupied B25003 | 54.4% | 77.0% | 62.6% |
| Renters B25003 | 45.6% | 23.0% | 37.4% |
| Median home value B25077 | $219,100 | $374,500 | $283,800 |
| Median gross rent B25064 | $1,379 | $1,807 | $1,403 |
| White, not Hispanic B03002 | 17.5% | 28.7% | 39.1% |
| Black B03002 | 13.1% | 20.6% | 11.9% |
| Hispanic or Latino B03002 | 58.4% | 24.7% | 39.7% |
| Asian B03002 | 9.0% | 21.9% | 5.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Rosenberg, TX.
Comments